Page last updated: 2024-11-03

propofol and Catatonia

propofol has been researched along with Catatonia in 3 studies

Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.

Catatonia: A neuropsychiatric disorder characterized by one or more of the following essential features: immobility, mutism, negativism (active or passive refusal to follow commands), mannerisms, stereotypies, posturing, grimacing, excitement, echolalia, echopraxia, muscular rigidity, and stupor; sometimes punctuated by sudden violent outbursts, panic, or hallucinations. This condition may be associated with psychiatric illnesses (e.g., SCHIZOPHRENIA; MOOD DISORDERS) or organic disorders (NEUROLEPTIC MALIGNANT SYNDROME; ENCEPHALITIS, etc.). (From DSM-IV, 4th ed, 1994; APA, Thesaurus of Psychological Index Terms, 1994)

Research Excerpts

ExcerptRelevanceReference
"Malignant catatonia (MC) is a movement disorder syndrome characterized by immobility, rigidity, and consciousness disorders that develops in association with mental and physical diseases."5.62Successful diagnosis and treatment of pulmonary aspergillosis-related malignant catatonia using propofol and quetiapine: A case report. ( Aisaka, W; Narimatsu, E; Nomura, K; Okamoto, H; Sakawaki, E; Sakawaki, S; Takeyama, Y; Uemura, S; Yamaoka, A, 2021)
"Malignant catatonia (MC) is a movement disorder syndrome characterized by immobility, rigidity, and consciousness disorders that develops in association with mental and physical diseases."1.62Successful diagnosis and treatment of pulmonary aspergillosis-related malignant catatonia using propofol and quetiapine: A case report. ( Aisaka, W; Narimatsu, E; Nomura, K; Okamoto, H; Sakawaki, E; Sakawaki, S; Takeyama, Y; Uemura, S; Yamaoka, A, 2021)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Nomura, K1
Sakawaki, S1
Sakawaki, E1
Yamaoka, A1
Aisaka, W1
Okamoto, H1
Takeyama, Y1
Uemura, S1
Narimatsu, E1
Li, EH1
Stork, CE1
Jim On, SC1
Bryson, EO1
Aloysi, AS1
Kellner, CH1
Kikuchi, A1
Yasui-Furukori, N1
Fujii, A1
Katagai, H1
Kaneko, S1

Other Studies

3 other studies available for propofol and Catatonia

ArticleYear
Successful diagnosis and treatment of pulmonary aspergillosis-related malignant catatonia using propofol and quetiapine: A case report.
    Medicine, 2021, May-14, Volume: 100, Issue:19

    Topics: Catatonia; Diagnosis, Differential; Female; Humans; Hypnotics and Sedatives; Middle Aged; Neurolepti

2021
Additional Procedures Performed During Electroconvulsive Therapy Anesthesia.
    The journal of ECT, 2016, Volume: 32, Issue:3

    Topics: Adolescent; Adult; Anesthesia; Anesthetics, Intravenous; Catatonia; Electroconvulsive Therapy; Femal

2016
Identification of predictors of post-ictal delirium after electroconvulsive therapy.
    Psychiatry and clinical neurosciences, 2009, Volume: 63, Issue:2

    Topics: Adult; Anesthesia, General; Catatonia; Delirium; Depressive Disorder, Major; Electroconvulsive Thera

2009